Abstract
We have previously purified and characterized a rat liver protein C′BP-1 that is either identical or closely related to C/EBPδ (). The mouse metallothionein-I (MT-I) promoter contains two C′BP-1 binding sites, one of which includes the MRE-c′ region (−135 to −110). The C′BP-1 binding activity was detected by EMSA as a major activity for MRE-c′ in nonproliferating adult liver cells but not in rat hepatoma cells. ln this study, we purified and characterized a factor, C′BP-2, which had a dominant binding activity for MRE-c′ in Morris hepatoma 3924A, a poorly differentiated, fast-growing tissue. C′BP-2 is a 28 kDa protein which exists in solution as a monomer. As observed for C′BP-1, affinity-purified C′BP-2 stimulated transcription from the mMT-I gene promoter. DNase I footprinting revealed two C′BP-2 binding sites in the regions that overlap with the CCAAT homologies of the C′BP-1 binding sites on the mMT-I promoter. C′BP-2 made essential contacts with the CCAAT homology and in the region upstream of this sequence. Competition electrophoretic mobility shift assay and methylation interference analysis revealed that C′BP-2 is a protein closely related, but not identical, to CP2. These data suggest that C′BP-1 and C′BP-2 may play a role in hepatocyte proliferation and/or differentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aniskovitch, L., Jacob, S. Distinct rat proteins can recognize CCAAT-homologous sequences of the metallothionein promoter and trans-activate this promoter. Oncogene 16, 1475–1486 (1998). https://doi.org/10.1038/sj.onc.1201659
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1201659